These data demonstrate that CPVT-associated CaM mutations can lead to a dominant pathogenic effect, which is consistent with an autosomal dominant inheritance pattern in humans. The gene discussed is CALM3; the disease is catecholaminergic polymorphic ventricular tachycardia.